Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates

NCT01954017 is registered in ClinicalTrials.gov with Leadiant Biosciences, Inc. as lead sponsor.

NCT NCT01954017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01954017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Lead sponsor
Leadiant Biosciences, Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 30, 2014
Completion date
October 22, 2018
Enrollment
103 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

necrotizing enterocolitis